CENTESSA PHARMACEUTICALS LIMITED
Company number 12973576 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-10-26
- Registered office
- Lilly House Basingview, Basingstoke, Hampshire, United Kingdom, RG21 4FA
- Postcode
- RG21 4FA
- Capital
- 310 GBP
- Accounts category
- Group
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-02-07
- Next due by
- 2027-02-21
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current · 15 resigned
Christopher J STOKES
Director
Kristina Mignon WRIGHT
Director
Group structure 1 subsidiary
From persons-with-significant-control filings on the public register.
Data protection registration
Registered with the ICO as a data protection fee payer — ZB271738 (Tier 2), registered since 2021.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Previous company names
| Name | Date changed |
|---|---|
| CENTESSA PHARMACEUTICALS PLC | 2026-09-07 |
| CENTESSA PHARMACEUTICALS LIMITED | 2021-05-14 |
| UNITED MEDICINES BIOPHARMA LIMITED | 2021-02-17 |
Previous registered addresses 1
| Address | Changed on |
|---|---|
| THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS, BABRAHAM, CAMBRIDGE, CB22 3FH, UNITED KINGDOM | 2021-05-04 |
The class of 2020
41%
of the 595 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.
A fact about the year, not a forecast for this company.